- Home
- DSX vs LYEL Comparison
DSX vs LYEL Comparison
Compare DSX & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSX
- LYEL
- Stock Information
- Founded
- DSX 1999
- LYEL 2018
- Country
- DSX Greece
- LYEL United States
- Employees
- DSX N/A
- LYEL N/A
- Industry
- DSX Marine Transportation
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- DSX Consumer Discretionary
- LYEL Health Care
- Exchange
- DSX Nasdaq
- LYEL Nasdaq
- Market Cap
- DSX 195.7M
- LYEL 207.7M
- IPO Year
- DSX 2005
- LYEL 2021
- Fundamental
- Price
- DSX $1.60
- LYEL $0.51
- Analyst Decision
- DSX Hold
- LYEL Sell
- Analyst Count
- DSX 1
- LYEL 2
- Target Price
- DSX $3.00
- LYEL $1.00
- AVG Volume (30 Days)
- DSX 290.7K
- LYEL 861.1K
- Earning Date
- DSX 05-27-2025
- LYEL 03-11-2025
- Dividend Yield
- DSX 2.51%
- LYEL N/A
- EPS Growth
- DSX N/A
- LYEL N/A
- EPS
- DSX 0.05
- LYEL N/A
- Revenue
- DSX $228,209,000.00
- LYEL $61,000.00
- Revenue This Year
- DSX N/A
- LYEL N/A
- Revenue Next Year
- DSX $12.03
- LYEL N/A
- P/E Ratio
- DSX $30.34
- LYEL N/A
- Revenue Growth
- DSX N/A
- LYEL N/A
- 52 Week Low
- DSX $1.56
- LYEL $0.48
- 52 Week High
- DSX $3.22
- LYEL $3.15
- Technical
- Relative Strength Index (RSI)
- DSX 31.08
- LYEL 41.67
- Support Level
- DSX $1.78
- LYEL $0.53
- Resistance Level
- DSX $1.80
- LYEL $0.63
- Average True Range (ATR)
- DSX 0.05
- LYEL 0.06
- MACD
- DSX -0.02
- LYEL -0.01
- Stochastic Oscillator
- DSX 14.29
- LYEL 17.32
About DSX Diana Shipping inc. common stock
Diana Shipping Inc provides shipping transportation services. The company, through its subsidiaries, operates a fleet of vessels consisting of dry bulk carriers such as Panamax, Kamsarmax, Post-Panamax, Capesize and Newcastlemax vessels. Using this fleet, the firm provides transportation services for various goods including coal, iron ore, and grains. It also transports minor bulks, including steel products, cement, and fertilizers through its dry bulk carrier vessels. The operation of the vessels is the main source of revenue generation, the services provided by the vessels are similar and all operate under the same economic environment.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.